Graham E J Rodwell, MD
Nephrology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 11
Offices
11 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: 052722 · 052793 · 552514 · 552559 · 752505 · Sequoia Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rodwell’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A76385 · Current
Licensed to practise in California · since 2001 · expires 2027-07-31 · University of Lund Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$262,385
Medicare paid this office $262,385 for 344 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $47,479 | $106 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 36 | $46,433 | $268 |
| Dialysis services, 1 physician visit per month (20 years or older) | 35 | $35,324 | $188 |
| Return visit (30+ min) | 189 | $33,893 | $113 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 14 | $18,293 | $321 |
See all 15 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $47,479 | $106 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 36 | $46,433 | $268 |
| Dialysis services, 1 physician visit per month (20 years or older) | 35 | $35,324 | $188 |
| Return visit (30+ min) | 189 | $33,893 | $113 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 14 | $18,293 | $321 |
| Critical care, first 30-74 minutes | 12 | $13,031 | $184 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $11,161 | $149 |
| Dialysis procedure including 1 evaluation | 15 | $10,093 | $79 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 11 | $9,885 | None |
| New patient visit (45+ min) | 49 | $6,816 | $139 |
| Long return visit (40+ min) | 18 | $3,967 | $172 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $2,693 | $71 |
| New patient visit (60+ min) | 13 | $2,508 | $193 |
| Hemodialysis procedure with physician evaluation | 17 | $1,590 | $64 |
| Injection of drug or substance under skin or into muscle | 11 | $734 | $14 |
Who their Medicare patients are
344 Original Medicare patients in 2024. Average age 77 · Under 65 7% · 85 and older 24% · Women 47% · Also on Medicaid 19% · Health risk score 3.18. At or below the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 49% · Coronary heart disease 39% · Heart failure 31% · Atrial fibrillation 31% · Depression 22% · Cancer 18% · COPD 14% · Dementia 12% · Stroke 8%.
The office billed $1,065,434, Medicare allowed $335,894 and paid $262,385; for 6,028 services of 24 kinds; $9,885 of it was for drugs given in the office and $252,499 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 344 | 6,028 | 77 | 3.18 | $1,065,434 | $262,385 |
| 2023 | 344 | 3,585 | 76 | 2.98 | $884,224 | $235,946 |
| 2022 | 408 | 2,993 | 76 | 2.68 | $894,943 | $248,055 |
| 2021 | 347 | 10,315 | 76 | 2.87 | $906,966 | $236,849 |
| 2020 | 355 | 11,612 | 76 | 3.14 | $864,042 | $207,244 |
| 2019 | 429 | 6,910 | 76 | 2.99 | $904,860 | $218,202 |
| 2018 | 401 | 5,821 | 75 | 2.94 | $813,262 | $203,140 |
| 2017 | 366 | 3,561 | 76 | 3.19 | $929,837 | $217,795 |
| 2016 | 440 | 2,265 | 76 | 2.99 | $1,105,251 | $189,472 |
| 2015 | 378 | 1,795 | 75 | 3.23 | $1,313,307 | $192,938 |
| 2014 | 365 | 2,229 | 74 | 3.76 | $1,138,705 | $151,434 |
| 2013 | 412 | 4,119 | 75 | 4.00 | $1,276,962 | $183,296 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 38 | $56,489 | $265 |
| Return visit (30+ min) | 200 | $40,427 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $32,448 | $110 |
| Home dialysis services per month (20 years or older) | 15 | $28,141 | $268 |
| Dialysis services, 1 physician visit per month (20 years or older) | 25 | $14,236 | $190 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $8,953 | $157 |
| New patient visit (45+ min) | 32 | $4,706 | $147 |
| Long return visit (40+ min) | 18 | $4,320 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $3,427 | $73 |
| New patient visit (60+ min) | 15 | $3,077 | $205 |
| Short return visit (20+ min) | 25 | $1,932 | $77 |
2022: 12 services
| Return visit (30+ min) | 265 | $48,652 | $108 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 32 | $44,404 | $274 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $36,394 | $94 |
| Home dialysis services per month (20 years or older) | 17 | $35,785 | $275 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 12 | $17,779 | $329 |
| Dialysis services, 1 physician visit per month (20 years or older) | 31 | $14,173 | $192 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $11,083 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $6,192 | $65 |
| Long return visit (40+ min) | 22 | $5,703 | $158 |
| New patient visit (45+ min) | 40 | $5,668 | $142 |
| New patient visit (60+ min) | 16 | $2,941 | $184 |
| Short return visit (20+ min) | 13 | $1,023 | $73 |
2021: 13 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 27 | $37,569 | $276 |
| Return visit (30+ min) | 208 | $37,226 | $109 |
| Home dialysis services per month (20 years or older) | 16 | $29,679 | $275 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 16 | $27,943 | $333 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $27,381 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $12,341 | $181 |
| Dialysis services, 1 physician visit per month (20 years or older) | 22 | $10,209 | $193 |
| Long return visit (40+ min) | 27 | $7,679 | $167 |
| New patient visit (45+ min) | 31 | $4,023 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $3,781 | $66 |
| New patient visit (60+ min) | 17 | $3,175 | $187 |
| Short return visit (20+ min) | 24 | $2,040 | $82 |
| Hemodialysis procedure with physician evaluation | 12 | $1,387 | $66 |
2020: 13 services
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 12 | $30,260 | None |
| Home dialysis services per month (20 years or older) | 14 | $29,223 | $221 |
| Return visit (30+ min) | 166 | $27,398 | $95 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 26 | $26,733 | $221 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $22,233 | $97 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 19 | $17,178 | $268 |
| Dialysis services, 1 physician visit per month (20 years or older) | 27 | $13,145 | $169 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $10,776 | $189 |
| New patient visit (45+ min) | 48 | $6,942 | $145 |
| Short return visit (20+ min) | 60 | $4,192 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $4,166 | $67 |
| Hemodialysis procedure with physician evaluation | 21 | $3,144 | $68 |
| Injection of drug or substance under skin or into muscle | 13 | $816 | $14 |
2019: 15 services
| Return visit (30+ min) | 214 | $37,474 | $93 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 28 | $23,529 | $218 |
| Home dialysis services per month (20 years or older) | 12 | $23,512 | $216 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $21,587 | $95 |
| Dialysis services, 1 physician visit per month (20 years or older) | 27 | $18,772 | $172 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 17 | $16,873 | $260 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $13,632 | $184 |
| New patient visit (45+ min) | 78 | $10,756 | $138 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $10,330 | $66 |
| Critical care, first 30-74 minutes | 14 | $7,747 | $199 |
| Short return visit (20+ min) | 58 | $4,217 | $60 |
| Long return visit (40+ min) | 18 | $3,726 | $138 |
| Dialysis procedure including 1 evaluation | 12 | $2,866 | $80 |
| Hemodialysis procedure with physician evaluation | 13 | $1,662 | $66 |
| Automated urinalysis test | 14 | $34 | $2 |
2018: 16 services
| Return visit (30+ min) | 212 | $33,736 | $93 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 26 | $26,778 | $216 |
| Home dialysis services per month (20 years or older) | 16 | $23,511 | $214 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 17 | $19,387 | $255 |
| Dialysis services, 1 physician visit per month (20 years or older) | 24 | $15,193 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $15,153 | $93 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 13 | $12,133 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $10,358 | $179 |
| New patient visit (45+ min) | 68 | $8,876 | $131 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $8,689 | $64 |
| Short return visit (20+ min) | 61 | $4,041 | $56 |
| Hemodialysis procedure with physician evaluation | 22 | $3,945 | $65 |
| Long return visit (40+ min) | 19 | $3,369 | $130 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,465 | $122 |
| Injection of drug or substance under skin or into muscle | 13 | $610 | $20 |
| Automated urinalysis test | 27 | $73 | $3 |
2017: 15 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 38 | $36,473 | $213 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 28 | $29,741 | $254 |
| Return visit (30+ min) | 181 | $28,368 | $90 |
| Home dialysis services per month (20 years or older) | 12 | $24,385 | $212 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $15,418 | $93 |
| Critical care, first 30-74 minutes | 11 | $15,308 | $196 |
| Dialysis services, 1 physician visit per month (20 years or older) | 26 | $12,201 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 50 | $11,076 | $65 |
| New patient visit (45+ min) | 70 | $10,079 | $144 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $8,916 | $178 |
| Short return visit (20+ min) | 42 | $2,780 | $57 |
| Long return visit (40+ min) | 15 | $2,401 | $126 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,585 | $122 |
| Hemodialysis procedure with physician evaluation | 17 | $1,400 | $64 |
| Automated urinalysis test | 19 | $57 | $3 |
2016: 17 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 24 | $30,636 | $210 |
| Return visit (30+ min) | 160 | $27,268 | $90 |
| New patient visit (45+ min) | 146 | $20,556 | $141 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $14,998 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 74 | $11,416 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $10,493 | $178 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 13 | $8,561 | $252 |
| Dialysis services, 1 physician visit per month (20 years or older) | 21 | $7,346 | $163 |
| Critical care, first 30-74 minutes | 16 | $5,864 | $195 |
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 13 | $5,205 | $217 |
| Hemodialysis procedure with physician evaluation | 27 | $3,563 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $3,276 | $121 |
| Long return visit (40+ min) | 15 | $2,935 | $122 |
| Short return visit (20+ min) | 36 | $2,746 | $56 |
| Insertion of needle and/or catheter for dialysis | 17 | $2,633 | $85 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 14 | $558 | $23 |
| Automated urinalysis test | 107 | $324 | $3 |
2015: 18 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $27,736 | $97 |
| Return visit (30+ min) | 135 | $23,817 | $95 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $18,422 | $222 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 82 | $18,404 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $14,465 | $188 |
| New patient visit (45+ min) | 75 | $11,028 | $147 |
| Dialysis services, 1 physician visit per month (20 years or older) | 15 | $8,969 | $172 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 12 | $8,697 | $264 |
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 15 | $7,502 | $227 |
| Critical care, first 30-74 minutes | 12 | $5,305 | $204 |
| Hemodialysis procedure with physician evaluation | 25 | $4,514 | $67 |
| Short return visit (20+ min) | 67 | $4,341 | $58 |
| Insertion of needle and/or catheter for dialysis | 22 | $4,229 | $90 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,779 | $126 |
| Insertion of tube into chest or arm artery, each first order branch | 12 | $1,955 | $109 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 15 | $1,015 | $32 |
| Review by radiologist of arm or leg artery image | 12 | $907 | $50 |
| Automated urinalysis test | 17 | $51 | $3 |
2014: 16 services
| Return visit (30+ min) | 114 | $18,629 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 95 | $18,576 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $12,728 | $92 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 15 | $12,511 | $212 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $9,401 | $177 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 13 | $8,601 | $253 |
| New patient visit (45+ min) | 58 | $8,190 | $141 |
| Short return visit (20+ min) | 82 | $6,996 | $61 |
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 19 | $5,489 | $220 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $4,215 | $120 |
| Hemodialysis procedure with physician evaluation | 36 | $4,038 | $64 |
| Insertion of needle and/or catheter for dialysis | 28 | $3,730 | $85 |
| Removal of tunneled central venous tube | 12 | $1,631 | $136 |
| Insertion of tube into chest or arm artery, each first order branch | 11 | $1,591 | $114 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 20 | $1,126 | $42 |
| Manual urinalysis test with examination using microscope, automated | 18 | $73 | $4 |
2013: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 90 | $21,772 | $88 |
| Return visit (30+ min) | 105 | $18,591 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 124 | $18,186 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 84 | $17,261 | $173 |
| Critical care, first 30-74 minutes | 24 | $12,522 | $190 |
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 22 | $9,019 | $196 |
| Short return visit (20+ min) | 97 | $8,625 | $62 |
| New patient visit (45+ min) | 44 | $5,864 | $133 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 14 | $5,417 | None |
| Dialysis procedure including 1 evaluation | 11 | $5,090 | $77 |
| Insertion of needle and/or catheter for dialysis | 30 | $4,697 | $89 |
| Hemodialysis procedure with physician evaluation | 44 | $4,282 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $3,067 | $118 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 22 | $1,140 | $25 |
| Injection of drug or substance under skin or into muscle | 13 | $591 | $26 |
| Manual urinalysis test with examination using microscope, automated | 22 | $99 | $4 |
Drugs they prescribed that Part D paid
$150,592
Pharmacies billed $150,592 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,272) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
1,197 generic and 75 brand-name prescriptions · $150,592 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lokelma | 18 | $35,685 | $1,983 |
| Veltassa | 12 | $19,646 | $1,637 |
| Sevelamer Carbonate | 35 | $14,231 | $407 |
| Calcitriol | 133 | $2,550 | $19 |
| Calcium Acetate | 27 | $2,114 | $78 |
See all 26 drugs
| Lokelma | 18 | $35,685 | $1,983 |
| Veltassa | 12 | $19,646 | $1,637 |
| Sevelamer Carbonate | 35 | $14,231 | $407 |
| Calcitriol | 133 | $2,550 | $19 |
| Calcium Acetate | 27 | $2,114 | $78 |
| Losartan | 113 | $1,210 | $11 |
| Valsartan | 18 | $952 | $53 |
| Amlodipine Besylate | 175 | $908 | $5 |
| Hydralazine | 45 | $854 | $19 |
| Furosemide | 123 | $782 | $6 |
| Carvedilol | 62 | $576 | $9 |
| Potassium Chloride | 20 | $511 | $26 |
| Bumetanide | 14 | $493 | $35 |
| Tamsulosin | 18 | $453 | $25 |
| Prednisone | 24 | $376 | $16 |
| Allopurinol | 31 | $323 | $10 |
| Chlorthalidone | 31 | $288 | $9 |
| Isosorbide Mononitrate Er | 11 | $238 | $22 |
| Ondansetron | 14 | $206 | $15 |
| Lisinopril | 32 | $191 | $6 |
| Metoprolol | 26 | $186 | $7 |
| Spironolactone | 23 | $133 | $6 |
| Clonidine | 20 | $121 | $6 |
| Levothyroxine | 11 | $52 | $5 |
| Benazepril | 12 | $47 | $4 |
| Hydrochlorothiazide | 11 | $24 | $2 |
Year by year
| 2024 | 1,272 | 196 | 0% (0) | 6% | $150,592 |
| 2023 | 1,231 | 184 | 0% (0) | 11% | $221,916 |
| 2022 | 1,162 | 179 | 0% (0) | 13% | $230,842 |
| 2021 | 1,235 | 175 | 0% (0) | None | $217,727 |
| 2020 | 1,472 | 183 | 0% (0) | None | $294,259 |
| 2019 | 1,482 | 197 | 0% (0) | None | $285,398 |
| 2018 | 1,614 | 207 | 0% (0) | None | $282,053 |
| 2017 | 1,545 | 200 | None | None | $283,788 |
| 2016 | 1,256 | 189 | None | 19% | $260,771 |
| 2015 | 1,098 | 128 | None | 26% | $156,314 |
| 2014 | 1,028 | 123 | None | 19% | $113,662 |
| 2013 | 900 | 112 | None | 28% | $75,005 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 29 drugs
| Lokelma | 42 | $64,612 | $1,538 |
| Velphoro | 14 | $37,805 | $2,700 |
| Renvela | 16 | $31,231 | $1,952 |
| Veltassa | 15 | $23,653 | $1,577 |
| Sevelamer Carbonate | 32 | $9,365 | $293 |
| Calcitriol | 155 | $3,692 | $24 |
| Losartan | 103 | $1,965 | $19 |
| Potassium Chloride | 30 | $1,344 | $45 |
| Amlodipine Besylate | 153 | $1,200 | $8 |
| Furosemide | 104 | $1,149 | $11 |
| Valsartan | 14 | $872 | $62 |
| Hydralazine | 40 | $794 | $20 |
| Metoprolol | 29 | $790 | $27 |
| Bumetanide | 18 | $772 | $43 |
| Carvedilol | 33 | $633 | $19 |
| Doxazosin Mesylate | 15 | $470 | $31 |
| Prednisone | 26 | $465 | $18 |
| Chlorthalidone | 22 | $436 | $20 |
| Allopurinol | 30 | $408 | $14 |
| Spironolactone | 18 | $348 | $19 |
| Tamsulosin | 16 | $315 | $20 |
| Lisinopril | 29 | $278 | $10 |
| Clonidine | 11 | $232 | $21 |
| Isosorbide Mononitrate Er | 13 | $197 | $15 |
| Minoxidil | 11 | $182 | $17 |
| Benazepril | 13 | $178 | $14 |
| Atorvastatin | 15 | $172 | $11 |
| Levothyroxine | 14 | $81 | $6 |
| Hydrochlorothiazide | 18 | $75 | $4 |
2022: 31 drugs
| Lokelma | 43 | $55,291 | $1,286 |
| Renvela | 23 | $53,208 | $2,313 |
| Velphoro | 16 | $45,437 | $2,840 |
| Veltassa | 19 | $24,641 | $1,297 |
| Sevelamer Carbonate | 28 | $13,197 | $471 |
| Cinacalcet | 15 | $4,535 | $302 |
| Calcitriol | 137 | $3,365 | $25 |
| Calcium Acetate | 15 | $1,514 | $101 |
| Tacrolimus | 15 | $1,474 | $98 |
| Losartan | 96 | $1,461 | $15 |
| Amlodipine Besylate | 147 | $916 | $6 |
| Hydralazine | 23 | $816 | $35 |
| Chlorthalidone | 40 | $810 | $20 |
| Minoxidil | 21 | $797 | $38 |
| Bumetanide | 12 | $722 | $60 |
| Furosemide | 97 | $718 | $7 |
| Nifedipine Er | 13 | $654 | $50 |
| Doxazosin Mesylate | 16 | $651 | $41 |
| Prednisone | 34 | $580 | $17 |
| Carvedilol | 33 | $529 | $16 |
| Metoprolol | 21 | $521 | $25 |
| Torsemide | 13 | $489 | $38 |
| Allopurinol | 25 | $478 | $19 |
| Potassium Chloride | 16 | $417 | $26 |
| Isosorbide Mononitrate Er | 12 | $394 | $33 |
| Benazepril | 13 | $211 | $16 |
| Spironolactone | 12 | $196 | $16 |
| Ondansetron | 13 | $189 | $15 |
| Lisinopril | 27 | $159 | $6 |
| Atorvastatin | 11 | $57 | $5 |
| Clonidine | 12 | $57 | $5 |
2021: 27 drugs
| Veltassa | 32 | $47,079 | $1,471 |
| Renvela | 20 | $43,357 | $2,168 |
| Lokelma | 29 | $26,286 | $906 |
| Sevelamer Carbonate | 48 | $15,578 | $325 |
| Cinacalcet | 15 | $8,124 | $542 |
| Calcitriol | 92 | $3,198 | $35 |
| Tacrolimus | 19 | $2,675 | $141 |
| Potassium Chloride | 18 | $1,740 | $97 |
| Calcium Acetate | 11 | $1,566 | $142 |
| Losartan | 90 | $1,514 | $17 |
| Amlodipine Besylate | 179 | $1,138 | $6 |
| Metoprolol | 29 | $898 | $31 |
| Furosemide | 93 | $880 | $9 |
| Doxazosin Mesylate | 21 | $788 | $38 |
| Prednisone | 55 | $700 | $13 |
| Minoxidil | 21 | $671 | $32 |
| Carvedilol | 37 | $480 | $13 |
| Hydralazine | 27 | $363 | $13 |
| Midodrine | 20 | $327 | $16 |
| Allopurinol | 18 | $285 | $16 |
| Lidocaine Hcl Viscous | 12 | $237 | $20 |
| Lisinopril | 39 | $215 | $6 |
| Pantoprazole | 13 | $192 | $15 |
| Ondansetron | 16 | $190 | $12 |
| Atorvastatin | 20 | $177 | $9 |
| Clonidine | 12 | $136 | $11 |
| Hydrochlorothiazide | 17 | $64 | $4 |
2020: 32 drugs
| Velphoro | 26 | $75,776 | $2,914 |
| Veltassa | 30 | $50,792 | $1,693 |
| Lokelma | 25 | $29,109 | $1,164 |
| Sevelamer Carbonate | 66 | $24,328 | $369 |
| Renvela | 11 | $21,555 | $1,960 |
| Tacrolimus | 21 | $4,521 | $215 |
| Calcitriol | 86 | $2,775 | $32 |
| Cyclosporine | 11 | $2,648 | $241 |
| Potassium Chloride | 22 | $1,904 | $87 |
| Losartan | 113 | $1,784 | $16 |
| Hydralazine | 73 | $1,638 | $22 |
| Amlodipine Besylate | 192 | $1,551 | $8 |
| Metoprolol | 40 | $1,469 | $37 |
| Doxazosin Mesylate | 25 | $1,171 | $47 |
| Furosemide | 118 | $966 | $8 |
| Calcium Acetate | 13 | $935 | $72 |
| Mycophenolate Mofetil | 13 | $891 | $69 |
| Clonidine | 11 | $808 | $73 |
| Carvedilol | 68 | $797 | $12 |
| Valsartan | 11 | $667 | $61 |
| Prednisone | 39 | $496 | $13 |
| Lisinopril | 65 | $448 | $7 |
| Isosorbide Mononitrate Er | 20 | $407 | $20 |
| Allopurinol | 29 | $404 | $14 |
| Clonidine | 21 | $303 | $14 |
| Tamsulosin | 12 | $277 | $23 |
| Lactulose | 28 | $237 | $8 |
| Ondansetron | 14 | $218 | $16 |
| Pantoprazole | 13 | $211 | $16 |
| Atorvastatin | 20 | $201 | $10 |
| Metoprolol | 14 | $69 | $5 |
| Hydrochlorothiazide | 13 | $52 | $4 |
2019: 30 drugs
| Veltassa | 52 | $88,165 | $1,695 |
| Renvela | 17 | $32,289 | $1,899 |
| Sevelamer Carbonate | 58 | $30,415 | $524 |
| Velphoro | 11 | $29,735 | $2,703 |
| Cyclosporine | 20 | $7,363 | $368 |
| Calcitriol | 128 | $3,168 | $25 |
| Calcium Acetate | 39 | $2,597 | $67 |
| Amlodipine Besylate | 181 | $2,033 | $11 |
| Metoprolol | 34 | $1,578 | $46 |
| Furosemide | 146 | $1,564 | $11 |
| Bumetanide | 13 | $1,468 | $113 |
| Potassium Chloride | 21 | $1,323 | $63 |
| Hydralazine | 58 | $1,304 | $22 |
| Losartan | 107 | $1,259 | $12 |
| Clonidine | 12 | $1,257 | $105 |
| Telmisartan | 14 | $602 | $43 |
| Minoxidil | 28 | $575 | $21 |
| Allopurinol | 31 | $566 | $18 |
| Isosorbide Mononitrate Er | 29 | $544 | $19 |
| Lisinopril | 54 | $539 | $10 |
| Carvedilol | 57 | $508 | $9 |
| Valsartan | 20 | $497 | $25 |
| Prednisone | 30 | $331 | $11 |
| Tamsulosin | 12 | $278 | $23 |
| Benazepril | 22 | $168 | $8 |
| Clonidine | 21 | $166 | $8 |
| Pantoprazole | 12 | $153 | $13 |
| Lactulose | 19 | $116 | $6 |
| Hydrochlorothiazide | 17 | $96 | $6 |
| Metoprolol | 13 | $95 | $7 |
2018: 27 drugs
| Renvela | 21 | $51,947 | $2,474 |
| Veltassa | 22 | $34,217 | $1,555 |
| Sevelamer Carbonate | 36 | $34,170 | $949 |
| Xifaxan | 11 | $24,174 | $2,198 |
| Sensipar | 21 | $17,794 | $847 |
| Clinisol | 48 | $9,689 | $202 |
| Calcium Acetate | 46 | $3,650 | $79 |
| Calcitriol | 142 | $3,364 | $24 |
| Amlodipine Besylate | 209 | $2,043 | $10 |
| Potassium Chloride | 40 | $1,428 | $36 |
| Furosemide | 179 | $1,199 | $7 |
| Losartan | 103 | $1,123 | $11 |
| Metoprolol | 25 | $927 | $37 |
| Valsartan | 27 | $808 | $30 |
| Hydralazine | 51 | $798 | $16 |
| Lisinopril | 59 | $554 | $9 |
| Nifedipine Er | 13 | $543 | $42 |
| Prednisone | 53 | $471 | $9 |
| Minoxidil | 26 | $379 | $15 |
| Allopurinol | 25 | $374 | $15 |
| Carvedilol | 46 | $311 | $7 |
| Clonidine | 39 | $292 | $7 |
| Tamsulosin | 13 | $276 | $21 |
| Levothyroxine | 18 | $229 | $13 |
| Hydrochlorothiazide | 22 | $175 | $8 |
| Lactulose | 20 | $171 | $9 |
| Spironolactone | 20 | $144 | $7 |
2017: 32 drugs
| Sensipar | 52 | $66,271 | $1,274 |
| Renvela | 40 | $57,447 | $1,436 |
| Xifaxan | 12 | $24,528 | $2,044 |
| Renagel | 14 | $14,643 | $1,046 |
| Clinisol | 44 | $8,713 | $198 |
| Calcium Acetate | 55 | $5,887 | $107 |
| Calcitriol | 123 | $3,031 | $25 |
| Bumetanide | 16 | $2,979 | $186 |
| Amlodipine Besylate | 170 | $1,361 | $8 |
| Potassium Chloride | 28 | $1,211 | $43 |
| Fludrocortisone Acetate | 14 | $952 | $68 |
| Midodrine | 18 | $889 | $49 |
| Furosemide | 125 | $847 | $7 |
| Valsartan | 28 | $829 | $30 |
| Metoprolol | 30 | $753 | $25 |
| Losartan | 82 | $607 | $7 |
| Lactulose | 23 | $487 | $21 |
| Hydralazine | 49 | $474 | $10 |
| Lisinopril | 60 | $473 | $8 |
| Clonidine | 36 | $440 | $12 |
| Entecavir | 11 | $398 | $36 |
| Allopurinol | 17 | $355 | $21 |
| Minoxidil | 18 | $339 | $19 |
| Tamsulosin | 12 | $320 | $27 |
| Donepezil | 11 | $258 | $23 |
| Prednisone | 26 | $253 | $10 |
| Isosorbide Mononitrate Er | 21 | $241 | $11 |
| Carvedilol | 36 | $194 | $5 |
| Hydrochlorothiazide | 24 | $187 | $8 |
| Levothyroxine | 27 | $177 | $7 |
| Spironolactone | 11 | $130 | $12 |
| Atenolol | 12 | $43 | $4 |
2016: 29 drugs
| Renvela | 47 | $112,800 | $2,400 |
| Sensipar | 54 | $66,892 | $1,239 |
| Xifaxan | 12 | $22,476 | $1,873 |
| Renagel | 11 | $10,213 | $928 |
| Clinisol | 52 | $9,142 | $176 |
| Calcium Acetate | 51 | $3,377 | $66 |
| Prosol | 23 | $2,308 | $100 |
| Calcitriol | 115 | $1,872 | $16 |
| Fludrocortisone Acetate | 11 | $853 | $78 |
| Tacrolimus | 11 | $843 | $77 |
| Potassium Chloride | 13 | $733 | $56 |
| Entecavir | 13 | $731 | $56 |
| Furosemide | 103 | $727 | $7 |
| Amlodipine Besylate | 150 | $714 | $5 |
| Hydralazine | 26 | $669 | $26 |
| Lidocaine-Prilocaine | 14 | $532 | $38 |
| Losartan | 62 | $460 | $7 |
| Amiloride | 14 | $454 | $32 |
| Metoprolol | 15 | $438 | $29 |
| Midodrine | 19 | $435 | $23 |
| Lisinopril | 44 | $421 | $10 |
| Valsartan | 13 | $378 | $29 |
| Clonidine | 21 | $321 | $15 |
| Spironolactone | 30 | $300 | $10 |
| Minoxidil | 20 | $285 | $14 |
| Prednisone | 22 | $266 | $12 |
| Carvedilol | 28 | $221 | $8 |
| Hydrochlorothiazide | 19 | $166 | $9 |
| Allopurinol | 15 | $142 | $9 |
2015: 29 drugs
| Renvela | 41 | $68,355 | $1,667 |
| Sensipar | 44 | $36,673 | $833 |
| Fosrenol | 12 | $10,277 | $856 |
| Clinisol | 53 | $6,314 | $119 |
| Calcium Acetate | 59 | $3,153 | $53 |
| Prosol | 19 | $1,289 | $68 |
| Entecavir | 11 | $1,191 | $108 |
| Fludrocortisone Acetate | 11 | $1,078 | $98 |
| Amlodipine Besylate | 103 | $1,031 | $10 |
| Potassium Chloride | 23 | $1,024 | $45 |
| Calcitriol | 81 | $943 | $12 |
| Furosemide | 136 | $826 | $6 |
| Lidocaine-Prilocaine | 18 | $715 | $40 |
| Chlorthalidone | 20 | $708 | $35 |
| Losartan | 46 | $549 | $12 |
| Amiloride | 13 | $418 | $32 |
| Midodrine | 12 | $356 | $30 |
| Lactulose | 11 | $354 | $32 |
| Lisinopril | 38 | $347 | $9 |
| Spironolactone | 46 | $325 | $7 |
| Metoprolol | 11 | $305 | $28 |
| Atorvastatin | 11 | $303 | $28 |
| Hydralazine | 22 | $292 | $13 |
| Hydrochlorothiazide | 13 | $222 | $17 |
| Clonidine | 15 | $195 | $13 |
| Minoxidil | 15 | $184 | $12 |
| Allopurinol | 12 | $123 | $10 |
| Carvedilol | 13 | $85 | $7 |
| Citalopram Hbr | 12 | $21 | $2 |
2014: 20 drugs
| Renvela | 44 | $50,425 | $1,146 |
| Sensipar | 30 | $22,007 | $734 |
| Clinisol | 59 | $8,670 | $147 |
| Calcium Acetate | 53 | $4,761 | $90 |
| Potassium Chloride | 31 | $2,164 | $70 |
| Fludrocortisone Acetate | 18 | $1,146 | $64 |
| Amlodipine Besylate | 84 | $1,061 | $13 |
| Calcitriol | 76 | $1,002 | $13 |
| Losartan | 63 | $850 | $13 |
| Lactulose | 12 | $655 | $55 |
| Hydralazine | 44 | $578 | $13 |
| Furosemide | 93 | $487 | $5 |
| Metoprolol | 14 | $460 | $33 |
| Hydrochlorothiazide | 33 | $415 | $13 |
| Lisinopril | 38 | $399 | $10 |
| Chlorthalidone | 15 | $371 | $25 |
| Clonidine | 31 | $305 | $10 |
| Spironolactone | 35 | $237 | $7 |
| Carvedilol | 14 | $184 | $13 |
| Allopurinol | 15 | $103 | $7 |
2013: 18 drugs
| Renvela | 48 | $31,896 | $665 |
| Clinisol | 55 | $8,081 | $147 |
| Sensipar | 18 | $5,794 | $322 |
| Calcium Acetate | 63 | $3,707 | $59 |
| Clonidine | 15 | $2,791 | $186 |
| Fludrocortisone Acetate | 17 | $1,122 | $66 |
| Losartan | 57 | $960 | $17 |
| Potassium Chloride | 27 | $763 | $28 |
| Furosemide | 109 | $742 | $7 |
| Amlodipine Besylate | 53 | $644 | $12 |
| Calcitriol | 48 | $591 | $12 |
| Pioglitazone | 11 | $398 | $36 |
| Clonidine | 47 | $381 | $8 |
| Omeprazole | 20 | $275 | $14 |
| Lisinopril | 25 | $257 | $10 |
| Spironolactone | 31 | $183 | $6 |
| Hydrochlorothiazide | 16 | $168 | $11 |
| Cephalexin | 11 | $73 | $7 |
Money from drug and device companies
$125 in 2025
| 2025 | 1 | 1 | None | $125 |
| 2023 | 2 | 2 | None | $56 |
| 2022 | 1 | 1 | None | $55 |
| 2020 | 2 | 2 | None | $47 |
| 2019 | 5 | 8 | None | $413 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Calliditas Therapeutics US | Tarpeyo | $125 | 1 payment
|
See the published payment
| Calliditas Therapeutics US | Meals · 2025-03-03 | Tarpeyo | $125 |
See earlier years (2023, 2022, 2020, 2019)
2023: $56
| Alexion Pharmaceuticals | Ultomiris | $31 | 1 payment
|
| Vifor Pharma | Veltassa | $25 | 1 payment
|
2022: $55
| Amgen | Tavneos | $55 | 1 payment
|
2020: $47
| Amgen | Parsabiv | $24 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $23 | 1 payment
|
2019: $413
| Bard Peripheral Vascular | None | $285 | 2 payments
|
| Otsuka America Pharmaceutical | Jynarque | $43 | 2 payments
|
| Amgen | Aranesp | $37 | 2 payments
|
| Fresenius USA Marketing | Velphoro | $25 | 1 payment
|
| Relypsa | Veltassa | $24 | 1 payment
|
Professional record
- NPI
- 1922077890
- Licence
- CA A76385California A76385: Current · expires 2027-07-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-03-14
- NPI last updated
- 2020-05-28
- NPI record certified
- 2020-05-28
This is when the NPI record was last certified, not a medical board exam.